002901 大博医疗
2026/03 - 三个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入641,49716.56%2,600,8602,135,5591,533,1211,434,099
减:营业总成本460,1269.19%1,948,7901,759,9301,459,1931,369,842
    其中:营业成本165,747-0.81%767,186667,258492,239333,920
               财务费用803-104.60%(30,825)(9,286)(23,186)(25,228)
               资产减值损失(15,298)62.38%(64,855)(43,413)(50,141)(12,055)
公允价值变动收益10,595360.73%49,4143,1095,6021,771
投资收益480-3.58%4,72017,2799,74716,206
    其中:对联营企业和合营企业的投资收益----------(120)
营业利润184,65543.97%737,644429,556103,216147,452
利润总额184,33543.86%730,044428,41499,721147,459
减:所得税费用22,44443.95%93,16543,12213,40537,892
净利润161,89043.85%636,879385,29286,316109,567
减:非控股权益15,32562.35%37,24728,48927,35617,012
股东净利润146,56642.16%599,632356,80358,96192,555

市场价值指针
每股收益 (元) *0.36044.00%1.4700.8600.1400.220
每股派息 (元) *----0.6000.5000.250--
每股净资产 (元) *8.99616.61%8.6237.4377.3877.246
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容